Literature DB >> 15971501

The ischemic electrocardiogram: a harbinger for ischemic heart disease independent of the blood pressure level. The Copenhagen City Heart Study.

Carsten Toftager Larsen1, Henry Blackburn, Niels Eske Bruun, Gorm Boje Jensen, Henrik Scharling, Peter Schnohr.   

Abstract

Information is limited on the co-existence and prognostic association of the ischemic electrocardiogram (ECG) and blood pressure. Prospectively collected data sets from 28,118 examinations in the Copenhagen City Heart Study were analyzed for cardiac morbidity and mortality for a 5.9-year follow-up. The prognosis of the ECG, independently of blood pressure, was examined. The Cox proportional hazard model was employed to evaluate the prognostic implications of ECG findings and relative risk was adjusted for age and multivariately adjusted for traditional cardiovascular risk factors. End-points were (1) fatal and non-fatal ischemic heart disease (IHD) events and (2) cardiovascular disease (CVD) mortality. During a total follow-up period of 166,471 person years (mean: 5.9 years) 1.481 IHD events were recorded and 1.051 CVD deaths. The relative risk of an ischemic ECG was independent of the blood pressure level. The multivariately adjusted relative risk for fatal and non-fatal IHD for the ischemic ECG was 1.70 (95% CI: 1.39-2.09, p < 0.001) in women, and 1.96 (95% CI: 1.67-2.30, p < 0.001) in men, and for CVD mortality 1.71 (95% CI: 1.34-2.17, p < 0.001) in women and 2.08 (95% CI: 1.74-2.49, p < 0.001) in men. An ECG with left ventricular hypertrophy (LVH) and ST-depression was the finding with the highest risk for future events. LVH by ECG voltage-only was associated with no statistically increased risk, except for men treated for arterial hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15971501     DOI: 10.1007/s10654-004-7535-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

2.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

3.  Prevalence and prognosis of electrocardiographic findings in middle-aged men.

Authors:  G Rose; P J Baxter; D D Reid; P McCartney
Journal:  Br Heart J       Date:  1978-06

4.  Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women.

Authors:  D De Bacquer; G De Backer; M Kornitzer; H Blackburn
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Bjorn Dahlof
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

7.  The electrocardiogram in prediction of sudden death: Framingham Study experience.

Authors:  B E Kreger; L A Cupples; W B Kannel
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

8.  Improved cardiovascular risk stratification by a simple ECG index in hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi; Erberto Carluccio; Guglielmo Benemio; Roberto Gattobigio; Claudia Borgioni; Maurizio Bentivoglio; Carlo Porcellati; Giuseppe Ambrosio
Journal:  Am J Hypertens       Date:  2003-08       Impact factor: 2.689

9.  Sex differential in the relationship of electrocardiographic ST-T abnormalities to risk of coronary death: 11.5 year follow-up findings of the Chicago Heart Association Detection Project in Industry.

Authors:  Y Liao; K Liu; A Dyer; J A Schoenberger; R B Shekelle; P Collette; J Stamler
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

10.  Silent ST-T changes in an epidemiologic cohort study--a marker of hypertension or coronary heart disease, or both: the Reykjavik study.

Authors:  E Sigurdsson; N Sigfusson; H Sigvaldason; G Thorgeirsson
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

View more
  2 in total

1.  Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up.

Authors:  Christina Ström Möller; Björn Zethelius; Johan Sundström; Lars Lind
Journal:  Heart       Date:  2007-05-04       Impact factor: 5.994

2.  Stage 2 Hypertension and Electrocardiogram Abnormality: Evaluating the Risk Factors of Cardiovascular Diseases in Nigeria.

Authors:  Shalom Nwodo Chinedu; Franklyn Nonso Iheagwam; Michael Kemjika Onuoha; Grace Nkechi Joshua; Opeyemi Christianah DeCampos
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.